A detailed history of National Bank Of Canada transactions in Sanofi stock. As of the latest transaction made, National Bank Of Canada holds 297,845 shares of SNY stock, worth $14.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
297,845
Previous 297,845 -0.0%
Holding current value
$14.3 Million
Previous $17.2 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$48.54 - $58.53 $2.94 Million - $3.55 Million
-60,595 Reduced 16.91%
297,845 $17.2 Million
Q2 2024

Aug 02, 2024

BUY
$45.39 - $50.36 $342,467 - $379,966
7,545 Added 2.15%
358,440 $17.4 Million
Q1 2024

May 13, 2024

BUY
$45.75 - $52.48 $548,817 - $629,550
11,996 Added 3.54%
350,895 $17.1 Million
Q4 2023

Feb 06, 2024

BUY
$43.13 - $54.79 $211,725 - $268,964
4,909 Added 1.47%
338,899 $16.9 Million
Q3 2023

Oct 10, 2023

SELL
$50.95 - $55.2 $874,149 - $947,066
-17,157 Reduced 4.89%
333,990 $17.9 Million
Q2 2023

Jul 26, 2023

BUY
$50.45 - $57.18 $827,834 - $938,266
16,409 Added 4.9%
351,147 $18.9 Million
Q1 2023

Apr 12, 2023

BUY
$45.86 - $54.45 $3.54 Million - $4.2 Million
77,130 Added 29.94%
334,738 $18.2 Million
Q4 2022

Jan 24, 2023

SELL
$38.86 - $48.55 $73,212 - $91,468
-1,884 Reduced 0.73%
257,608 $0
Q3 2022

Oct 13, 2022

SELL
$37.22 - $100.5 $206,496 - $557,574
-5,548 Reduced 2.09%
259,492 $9.69 Million
Q2 2022

Jul 28, 2022

BUY
$48.99 - $57.46 $107,288 - $125,837
2,190 Added 0.83%
265,040 $13.3 Million
Q1 2022

May 05, 2022

BUY
$48.48 - $53.65 $83,724 - $92,653
1,727 Added 0.66%
262,850 $13.5 Million
Q4 2021

Jan 24, 2022

BUY
$47.07 - $52.35 $12.3 Million - $13.7 Million
261,123 New
261,123 $13.1 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.